Abstract
Background and aimsPseudomonas aeruginosa (PsA) is associated with considerable morbidity and mortality in Non-Cystic Fibrosis bronchiectasis (NCFB) and Cystic Fibrosis (CF) patients. Ticarcillin, a carboxypenicillin, is occasionally used in NCFB...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have